N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide

C24H27N5O4 — CID 123149479

IUPACN-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide
SMILES[H]/N=C1/C(c2nc3ccccc3[nH]2)C(=O)C(C)(CCNC(C)=O)N1c1cc(OC)cc(OC)c1
InChIInChI=1S/C24H27N5O4/c1-14(30)26-10-9-24(2)21(31)20(23-27-18-7-5-6-8-19(18)28-23)22(25)29(24)15-11-16(32-3)13-17(12-15)33-4/h5-8,11-13,20,25H,9-10H2,1-4H3,(H,26,30)(H,27,28)/b25-22-
InChIKeyQOLURPOMEHDVHO-LVWGJNHUSA-N
MW449.51 g/mol
LogP3.02
Rot. Bonds7

About N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide

N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide (PubChem CID 123149479) has the molecular formula C24H27N5O4 and a molecular weight of 449.51 g/mol. Its IUPAC name is N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide.

Molecular Properties

Compound NameN-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide
PubChem CID123149479
Molecular FormulaC24H27N5O4
Molecular Weight449.51 g/mol
Exact Mass449.21
IUPAC NameN-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide
SMILES[H]/N=C1/C(c2nc3ccccc3[nH]2)C(=O)C(C)(CCNC(C)=O)N1c1cc(OC)cc(OC)c1
InChIInChI=1S/C24H27N5O4/c1-14(30)26-10-9-24(2)21(31)20(23-27-18-7-5-6-8-19(18)28-23)22(25)29(24)15-11-16(32-3)13-17(12-15)33-4/h5-8,11-13,20,25H,9-10H2,1-4H3,(H,26,30)(H,27,28)/b25-22-
InChIKeyQOLURPOMEHDVHO-LVWGJNHUSA-N
XLogP3.02
TPSA120.40 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500449.51
LogP ≤ 53.02
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide?
The IUPAC name of N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide (CID 123149479) is N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide.
What is the SMILES notation for N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide?
The canonical SMILES for N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide is [H]/N=C1/C(c2nc3ccccc3[nH]2)C(=O)C(C)(CCNC(C)=O)N1c1cc(OC)cc(OC)c1.
What is the InChIKey of N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide?
The InChIKey is QOLURPOMEHDVHO-LVWGJNHUSA-N. The full InChI is InChI=1S/C24H27N5O4/c1-14(30)26-10-9-24(2)21(31)20(23-27-18-7-5-6-8-19(18)28-23)22(25)29(24)15-11-16(32-3)13-17(12-15)33-4/h5-8,11-13,20,25H,9-10H2,1-4H3,(H,26,30)(H,27,28)/b25-22-.
What are the key properties of N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide?
N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide has a molecular weight of 449.51 g/mol, XLogP of 3.02, 7 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(1H-benzimidazol-2-yl)-1-(3,5-dimethoxyphenyl)-5-imino-2-methyl-3-oxopyrrolidin-2-yl]ethyl]acetamide is sourced from PubChem (CID 123149479), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).